Immune booster shot before breast surgery shows promise in early trial
Disease control
Not yet recruiting
This early-phase trial tests whether giving an immune-boosting drug (Mitazalimab) alone or with another drug (Nivolumab) directly into the tumor before surgery is safe and helps the immune system fight breast cancer. About 32 adults with early-stage or recurrent breast cancer tha…
Phase: EARLY_PHASE1 • Sponsor: Jennifer Zhang • Aim: Disease control
Last updated May 04, 2026 16:20 UTC